Response to the Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial"

Zhidong Gao, Chao Wang^{1

2}, Zhuang Tao³, Yingjiang Ye^{1

2}

Affiliations

¹ Department of Gastrointestinal Surgery, Peking University People's Hospital, Beijing, China.
² Laboratory of Surgical Oncology, Peking University People's Hospital, Beijing, China.
³ Beijing Medical Development Clinical Research Institute, Beijing, China.

Comment

Zhidong Gao et al. Ann Surg. 2021.

. 2021 Dec 1;274(6):e755-e756.

doi: 10.1097/SLA.0000000000004273.

Zhidong Gao, Chao Wang^{1

2}, Zhuang Tao³, Yingjiang Ye^{1

2}

¹ Department of Gastrointestinal Surgery, Peking University People's Hospital, Beijing, China.
² Laboratory of Surgical Oncology, Peking University People's Hospital, Beijing, China.
³ Beijing Medical Development Clinical Research Institute, Beijing, China.

No abstract available

Conflict of interest statement

The authors report no conflicts of interest.

Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial.
Gao Z, Wang C, Cui Y, Shen Z, Jiang K, Shen D, Wang Y, Zhan S, Guo P, Yang X, Liu F, Shen K, Liang B, Yin M, Xie Q, Wang Y, Wang S, Ye Y. Gao Z, et al. Ann Surg. 2020 Mar;271(3):519-526. doi: 10.1097/SLA.0000000000003012. Ann Surg. 2020. PMID: 30148752 Clinical Trial.
Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial".
Souadka A, Majbar MA, Essangri H, Benkabbou A, Amrani L, Mohsine R, Maggiori L. Souadka A, et al. Ann Surg. 2021 Dec 1;274(6):e754-e755. doi: 10.1097/SLA.0000000000004284. Ann Surg. 2021. PMID: 33074880 No abstract available.

1. Gao Z, Wang C, Cui Y, et al. Efficacy and safety of complete mesocolic excision in patients with colon cancer: three-year results from a prospective, nonrandomized, double-blind, controlled trial. Ann Surg 2020; 271:519–526.
1. Gao Z, Wang C, Zhan S, et al. Response to comment on “Controlling for ascertainment bias may introduce control group bias in prospective nonrandomized trials”. Ann Surg 2019; 270:e55.
1. Wang C, Gao Z, Shen K, et al. Safety, quality and effect of complete mesocolic excision vs non-complete mesocolic excision in patients with colon cancer: a systemic review and meta-analysis. Colorectal Dis 2017; 19:962–972.
1. Bertelsen CA, Neuenschwander AU, Jansen JE, et al. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol 2015; 16:161–168.
1. Munkedal DLE, Rosenkilde M, Nielsen DT, et al. Radiological and pathological evaluation of the level of arterial division after colon cancer surgery. Colorectal Dis 2017; 19:O238–O245.